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n INTRODUCTION
Septicaemia is a critical disease in the neona-tal period and during infancy [1-3]. Bacteri-al infections in infants (particularly preterm
infants) may immediately lead to generalised
sepsis, and if not treated accordingly, may lead
to high rates of morbidity and mortality. This
disease has non-specific signs and symptoms
that must be treated properly and quickly; oth-
erwise, they can disrupt the clinical status of pa-
tients and become life-threatening [4].
The incidence in some countries is low (1.4%-
3.2%), although early onset and late onset septi-
caemia have different incidences but other fac-
tors such as gestational age play a major role in
the incidence of septicaemia, which increases
with decreasing gestational age [1-3]. In addi-
tion, the case fatality rate for early and late on-
set sepsis has been reported as high as 40% and
19.7%, respectively [5]. According to a report of
the World Health Organization, about five mil-
lion deaths are caused annually by neonatal
septicaemia [6]. 
Early diagnosis of sepsis in neonates and in-
fants presents a clinical dilemma. A common
method is to be guided by blood culture results
after 48 to 72 hours of incubation, by which
time 98% of cultures ultimately yielding an or-
ganism will be positive. However, initiation of
antibiotic therapy before obtaining the diagnos-
tic results is recommended for neonates and in-
fants with clinical signs or epidemiological fac-
tors associated with sepsis. 
Previous studies reported low sensitivity for
white blood cell (WBC) counts in the diagnosis
of infections in infants. Moreover, the combina-
tion of some paraclinical tests such as total
neutrophil count, ratio of immature neu-
trophils to total neutrophil count, and platelet
count are not adequately sensitive or specific
for the diagnosis of sepsis in infants, although
another study showed that two serial normal
immature to total neutrophil ratio accompa-
nied with negative blood culture could be in-
dicative of a non-infected neonate [7-9, 3].
C-reactive protein (CRP) is an acute-phase pro-
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tein found in the blood, whose levels rise in re-
sponse to inflammation within six to eight
hours [10]. CRP with a half life of 19 hours may
increase more than 1000 fold following an in-
fection [11]. In some studies, CRP levels in-
creased in septic infants [12, 13]. However, an-
other study indicated that measuring CRP lev-
els is not efficient for the early diagnosis of in-
fections in infants, since they are useful for con-
firmation or rejection of an infection 24 hours
after infection is suspected [14]. 
Sepsis and endotoxins activate monocytes,
macrophages, lymphocytes, fibroblasts and en-
dothelial cells. These activated cells produce
and secrete substances such as interleukin-1(IL-
1), tumour necrosis factor-α (TNF-α), interfer-
on-α, IL-6, IL-8, and other proinflammatory cy-
tokines. IL-1β is a member of the interleukin 1
cytokine family. This cytokine is produced by
activated macrophages as a proprotein, which
is proteolytically processed to its active form by
caspase 1 (CASP1/ICE). This cytokine is an im-
portant mediator of the inflammatory response.
Clinical signs and symptoms in neonatal sepsis
are non-specific, and in addition laboratory pa-
rameters such as WBC count, erythrocyte sedi-
mentation rate and CRP levels are of limited di-
agnostic value, and standard diagnostic proce-
dures may delay treatment and result in poor
prognosis [7, 15-19]. 
There is still no satisfactory test capable of ear-
ly and rapid diagnosis of sepsis in infants.
Therefore the aim of this study was to compare
serum IL-1beta and C-reactive protein levels in
early diagnosis and management of neonatal
sepsis.
n PATIENTS AND METHODS
In this cross-sectional study, blood samples
were obtained from 83 infants hospitalised in a
children’s hospital in Qazvin in whom infection
was suspected. This study was approved by the
ethics committee of Qazvin University of Med-
ical Sciences and all parents completed the in-
formed consent form.
After the infants were admitted and examined
by paediatricians and subspecialists, routine
tests for sepsis were arranged and blood sam-
ples were collected. The infants that presented
with more than three of the following signs and
symptoms of sepsis were screened for sepsis:
• maternal risk factors such as maternal fever,
alcohol consumption, premature rupture of
membranes (more than 24 hours), chorioam-
nionitis, and maternal urinary tract infection
[20];
• neonatal risk factors such as low birth
weight (less than 2500 g) and premature
birth (less than 37 weeks) [20];
• signs and symptoms of sepsis, including
anorexia, lethargy, temperature instability
(fever and hypothermia), jaundice, apnea,
respiratory distress, tachycardia (>180/
min), tachypnea (>60/min), cyanosis, and
vomiting [4, 19, 20].
To perform serum IL-1β and quantitative CRP
tests, blood samples were placed in ice contain-
ers and delivered to the laboratory. The serum
was removed from the blood samples at 4°C
and kept in refrigerators at -30°C until the time
of testing. 
A mini nephelometric device (The Binding Site
Company, Birmingham, UK) was used to mea-
sure CRP. All samples were diluted with the
nephelometry dilution solution at a 1/40 ratio.
Twenty microlitres of each serum sample were
poured into a cuvette and placed in the cuvette
chamber of the nephelometer. Then 400 μL of
CRP buffer and 40 μL of CRP reagent were
added to the cuvette, which was immediately
placed inside the nephelometer. In this reac-
tion, the CRP present in the serum binds to
polystyrene microparticles and forms an anti-
gen-antibody complex; these resultant immune
complexes are exposed to the laser beam of the
device. 
The scattering intensity of the laser beam mea-
sured by the device is proportional to the con-
centration of the CRP in the samples. A serum
CRP level >10 mg/L was considered abnormal.
IL-1β levels were measured by enzyme-linked
immunosorbent assay (ELISA). Microplates
were covered with monoclonal antibodies
against IL-1β. First, 50 μL of serum from each
patient and 50 μL of assay buffer were added to
each well. Serial dilutions were made from the
standard solution and added to the wells. A 50
μL-volume of monoclonal IL-1β conjugated to
biotin was added to each well. After 2-hr incu-
bation at room temperature and 4 rinses, 100 μL
of streptavidin horseradish peroxidase (HRP)
was added to the wells. Following 1-hr incuba-
tion at room temperature and 4 rinses, 100 μL of
substrate solution was added to the wells. After
15 min, the reaction was stopped using stop-
ping solution and the contents of the plates
were read at 450 and 620 nm with an ELISA
plate reader. The concentration of IL-1β was
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calculated by drawing the standard curve. 
Phase I culture medium D was used to perform
the blood culture. The culture medium was
added to 1-3 mL of blood and the cultures were
placed into an incubator for 5 days at 35°C. The
cultures were examined daily for bacterial
growth. If bacterial growth was observed, se-
lective media were used to identify the type of
bacterium present in the cultures. Urine and
cerebrospinal fluid (CSF) cultures were also
performed for all subjects. 
Gold standard criteria for diagnosis of sepsis
were as follows: 
• documentation of a positive culture from
blood, CSF or urine [21];
• clinical signs of sepsis with two or more of
the following para-clinical results: WBC
count <4000 or >10000 per mm3, band cells
to total neutrophil count ratio >0.2 and a
positive acute phase reactant test [4]. 
The collected data were analysed by indepen-
dent sample T-test. The sensitivity, specificity,
positive predictive value (PPV) and negative
predictive value (NPV) were calculated for the
IL-1β and CRP in comparison to the gold stan-
dard.
n RESULTS
In this study, samples from 83 infants (41 girls
and 42 boys) were examined. There were 12
positive blood cultures, 1 positive cerebrospinal
fluid culture, and 3 positive urine cultures
among the 83 samples (Table 1). The serum
samples were tested to measure IL-1β by ELISA.
The horizontal line that was drawn for IL-1β
was equal to the cutoff value of 3.72 pg/mL. 
Among the 83 patients, 60 patients showed neg-
ative results for IL-1β and 23 patients showed
positive IL-1β results. The sensitivity, specifici-
ty, PPV and NPV of the IL-1β ELISA for diag-
nosis of sepsis were 27%, 71%, 25% and 73%, re-
spectively. The sensitivity, specificity, PPV and
NPV of the IL-1β for diagnosis of positive blood
culture were 33%, 74%, 18% and 86%, respec-
tively.
CRP was measured upon patient admission
prior to the initiation of treatment. The horizon-
tal line that was drawn for CRP was equal to
the cutoff value of 10 mg/L. Serum CRP levels
<10 mg/L were considered negative and those
>10 mg/L were considered positive. The nega-
tive and positive CRP rates of the patients were
26 and 57, respectively. The sensitivity, speci-
ficity, PPV, and NPV of the serum quantitative
CRP for diagnosis of sepsis were 76%, 60%,
40%, and 88%, respectively.
n DISCUSSION
Microbial infection remains a major cause of in-
fant death. Given that prognosis of sepsis in in-
fants largely depends on an immediate diagno-
sis and appropriate antibiotic treatment, pa-
tients undergo extensive laboratory testing and
empirical antibiotic treatment. The final diag-
nosis of sepsis is confirmed by blood culture,
which lasts at least 48-72 hr and shows positive
results in 30-70% cases. Furthermore, advanced
blood testing may not be available in all health
centres [4].
Numerous studies have been conducted using
laboratory tests for sepsis; however, there is still
no satisfactory test capable of accurately diag-
nosing sepsis in infants [4, 13, 18, 22-25]. Due to
the importance of immediate diagnosis of sep-
sis, haematological parameters have also been
examined. Most researchers conclude that ex-
amining haematological parameters in septic
infants with negative blood cultures may be
useful [25, 26]. The study conducted by Shirazi
et al. reported that the sensitivity and specifici-
ty of haematological parameters were 60% and
70%, respectively. 
A study by Kurt et al. of haematological para-
meters found that the sensitivity and specificity
of absolute neutrophil count were 71.4% and
88%, respectively [4]. Over the last few decades,
it has been reported that production of various
mediators of inflammation increases during
sepsis. Studies of cytokines such as IL-1β and
Table 1 - Characteristics of the positive cultures.
Sample Type of microorganisms Number
Blood Klebsiella spp 4
Coagulase negative 
staphylococci 3
Escherichia coli 2
Staphylococcus epidermidis 1
Coagulase positive 
staphylococci 1
Urine Klebsiella spp 2
Escherichia coli 1
Cerebrospinal Escherichia coli 1
fluid
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TNF-α, which are produced during the initia-
tion of inflammatory cascade, have yielded dif-
fering results. In the study by Kurt et al., serum
levels of IL-1β and TNF-α in septic infants in-
creased considerably.
However, other studies have reported results
that were contrary to those of the present study
[27- 30]. Another study by Atici et al. found that
serum IL-1β levels decreased in septic infants.
Furthermore, serum IL-1β levels were not de-
pendent on whether the infection was caused
by gram-negative or gram-positive microor-
ganisms. 
The authors concluded that serum IL-1β levels
decreased both in preterm and term infants and
that the gestational age was inconsequential
[31]. The results of the above study were also
inconsistent with those of the present study. In
a separate study reported by Ucar et al., serum
levels of IL-1β in septic infants were also low,
contrary to the findings of the present study
[32]. Interestingly, it appears that the mono-
cytes of infants are unable to secrete sufficient
IL-1β and prostaglandin E2, and IL-6 may also
suppress secretion of IL-1β and TNF-α in in-
fants [22, 29-33]. Similar to the present study,
quantitative analysis of CRP as an acute phase
reactant by Ucar et al. had a rather high sensi-
tivity and specificity [32]. 
Utilization of quantitative instead of qualitative
CRP and comparing its results with Il-1β is the
strength of this study. The limitations of the
present study are the cross sectional design and
the small population size.
Based on the results of the present study and
other studies reported in the literature, quanti-
tative serum CRP measurement could be a suit-
able test to diagnose sepsis in infants. More-
over, the advantage of this approach lies in the
reduction in the number of infant ward admis-
sions as well as a reduced number of admission
days. Conducting similar experiments in devel-
oping countries in which hospital facilities and
resources are limited might be quite advanta-
geous.
Acknowledgments
We would like to thank our colleagues including
Mrs. Fatemeh Salimi, Ms. J. Pourrezaei, Ali Azimi-
an-asl and Mrs Zahra Khodabandehloo and the staff
of the Center for Clinical Research at Qazvin Chil-
dren Hospital, affiliated to Qazvin University of
Medical Sciences. This research was officially regis-
tered as project No. 867 at the College of Medicine,
Qazvin University of Medical Sciences.
Keywords: Il-1Beta, CRP, sepsis, newborn, diag-
nosis.
Clinical signs and symptoms of non-infectious dis-
eases are similar to those of infectious diseases
during infancy. 
Therefore, rapid new methods for diagnosis of in-
fections in infants are urgently needed. To exam-
ine the utility of measuring serum IL-1β for imme-
diate diagnosis of sepsis in infants, in this cross-
sectional epidemiological study blood samples
were taken from 83 infants (41 female and 42 male)
in whom infection was suspected and who were
admitted to hospital. 
To perform serum interleukin (IL)-1β and quanti-
tative C-reactive protein (CRP) tests, blood sam-
ples were placed in ice containers and delivered to
the laboratory. The serum was removed from the
samples at 4°C and stored in refrigerators at −30°C
until the time of testing. 
The results were analysed by t tests. Sensitivity,
specificity, positive predictive value (PPV), and
negative predictive value (NPV) of serum IL-1β
were 27%, 71%, 25%, and 73%, respectively. Sensi-
tivity, specificity, PPV and NPV of serum quanti-
tative CRP were 76%, 60%, 40% and 88%, respec-
tively. 
Hence quantitative serum CRP measurement for
the diagnosis of infections is more efficient than
measuring serum IL-1β levels. In general, quanti-
tative serum CRP measurement as an alternative
to other tests such as serum IL-1β assays might be
an ideal test for diagnosing infections in infants.
SUMMARY
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La similitudine che si riscontra, nell’età infantile, tra se-
gni clinici e sintomi delle malattie infettive e non infet-
tive rende necessario poter disporre di nuovi e rapidi
metodi per la diagnosi di infezione nel neonato.
Nell’intento di valutare l’utilità della determinazione
dei livelli sierici di interleuchina (IL)-1β per la diagnosi
immediata di sepsi nel neonato, in questo studio epide-
miologico cross-sezionale sono stati raccolti campioni di
sangue da 83 neonati (41 femmine e 42 maschi) ricove-
rati in ospedale per sospetto di infezione. Per effettuare
i test di rilevazione della IL-1β sierica e della proteina C
reattiva (PCR), i campioni di sangue sono stati posti in
contenitori con ghiaccio e inviati al laboratorio dove il
siero di ciascun campione è stato congelato a -30°C fino
al momento del test. I risultati sono stati analizzati con
il t test. Sensibilità, specificità, valore predittivo positi-
vo (PPV), e valore predittivo negativo (NPV) relativi
alla determinazione della IL-1β sierica sono risultati pa-
ri a 27%, 71%, 25%, e 73%, rispettivamente. Sensibi-
lità, specificità, PPV e NPV relativi alla determinazio-
ne quantitativa della PCR sierica sono risultati pari a
76%, 60%, 40% e 88%, rispettivamente. Per la diagno-
si di infezione, dunque, la misura quantitativa della
PCR è più efficiente rispetto a quella della IL-1β. In li-
nea generale, la determinazione quantitativa della PCR
nel siero in alternativa ad altri test, quale la determina-
zione della IL-1β sierica, potrebbe costituire un test ot-
timale per la diagnosi di infezione nel neonato.
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